Abstract
Being afraid of inadequate dialysis, thrice-weekly HD has been regarded as a standard renal replacement therapy (RRT) for ESRD patients [1]. Nevertheless, twice-weekly HD remains prevalent in the developing countries and also could be found in some developed countries [2,3]. Thus far, scarce data are available for the clinical outcomes, especially intradialytic hypotension (IDH), of twice-weekly HD patients. Few studies have used a rigorous definition of IDH according to the European Best Practice Guidelines (EBPG), which defines as both a fall blood pressure and the occurrence of symptoms requiring an intervention [4].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
